Genes in panel
STRs in panel
Prev Next
Regions in panel
Prev Next

Genetic Epilepsy

Gene: PDSS2

Amber List (moderate evidence)

PDSS2 (decaprenyl diphosphate synthase subunit 2)
EnsemblGeneIds (GRCh38): ENSG00000164494
EnsemblGeneIds (GRCh37): ENSG00000164494
OMIM: 610564, Gene2Phenotype
PDSS2 is in 9 panels

2 reviews

Ain Roesley (Victorian Clinical Genetics Services)

Green List (high evidence)

PMID: 29032433;
1x but paternal variant is a large deep intronic deletion (NM_020381.3:c.1042_1148-2816del) and RNA studies were not done

PMID: 25349199;
2x from steroid-resistant nephrotic syndrome cohort

PMID:17186472;
1x infant

PMID: 21723727 was cited to have done the molecular for family reported in PMID:10972372 but I was unable to find this information/genotype
Created: 31 Jan 2022, 4:16 a.m. | Last Modified: 31 Jan 2022, 4:16 a.m.
Panel Version: 0.10813

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Coenzyme Q10 deficiency, primary, 3 MIM#614652

Publications

Variants in this GENE are reported as part of current diagnostic practice

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

I don't know

Seizures /encephalotpathy reported; however, I can only find 2 families in the literature.
Created: 25 Jan 2020, 1:08 a.m. | Last Modified: 25 Jan 2020, 1:08 a.m.
Panel Version: 0.413

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Coenzyme Q10 deficiency, primary, 3, MIM#614652

Publications

Details

Mode of Inheritance
Unknown
Sources
  • Expert Review Amber
  • Victorian Clinical Genetics Services
  • Australian Genomics Health Alliance Epilepsy Flagship
Phenotypes
  • Coenzyme Q10 deficiency, primary, 3, MIM#614652
OMIM
610564
Clinvar variants
Variants in PDSS2
Penetrance
None
Publications
Panels with this gene

History Filter Activity

25 Jan 2020, Gel status: 2

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: pdss2 has been classified as Amber List (Moderate Evidence).

25 Jan 2020, Gel status: 2

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Phenotypes for gene: PDSS2 were changed from to Coenzyme Q10 deficiency, primary, 3, MIM#614652

25 Jan 2020, Gel status: 2

Set publications

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Publications for gene: PDSS2 were set to

25 Jan 2020, Gel status: 2

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: pdss2 has been classified as Amber List (Moderate Evidence).

17 Nov 2019, Gel status: 3

Created, Added New Source, Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

gene: PDSS2 was added gene: PDSS2 was added to Genetic Epilepsy_AustralianGenomics_VCGS. Sources: Australian Genomics Health Alliance Epilepsy Flagship,Expert Review Green,Victorian Clinical Genetics Services Mode of inheritance for gene: PDSS2 was set to Unknown